Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Nature Communications|August 29, 2018
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylationEun-Jin Bae, Dong-Kyu Kim, Changyoun Kim, et al.
Nature Medicine|February 10, 2009
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseAlan H Nagahara, David A Merrill, Giovanni Coppola, et al.
Scientific Reports|February 8, 2019
The Amazon rain forest plant Uncaria tomentosa (cat's claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tanglesAlan D Snow, Gerardo M Castillo, Beth P Nguyen, et al.
Autophagy|December 5, 2017
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotypeGeorgia Minakaki, Stefanie Menges, Agnes Kittel, et al.
Neuron|September 4, 2015
Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy PathogenesisYingjun Zhao, I-Chu Tseng, Charles J Heyser, et al.
Frontiers in Neuroscience|August 18, 2025
Correction: Nicotine-mediated effects in neuronal and mouse models of synucleinopathyMohamed Bilal Fares, Omar Alijevic, Stephanie Johne, et al.
Frontiers in Neuroscience|September 18, 2023
Nicotine-mediated effects in neuronal and mouse models of synucleinopathyMohamed Bilal Fares, Omar Alijevic, Stephanie Johne, et al.
Neurobiology of Disease|August 25, 2019
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivoDarren J Schofield, Lorraine Irving, Laura Calo, et al.
Brain : a Journal of Neurology|September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's diseaseWolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Nature Communications|August 29, 2018
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylationEun-Jin Bae, Dong-Kyu Kim, Changyoun Kim, et al.
Nature Medicine|February 10, 2009
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseAlan H Nagahara, David A Merrill, Giovanni Coppola, et al.
Scientific Reports|February 8, 2019
The Amazon rain forest plant Uncaria tomentosa (cat's claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tanglesAlan D Snow, Gerardo M Castillo, Beth P Nguyen, et al.
Autophagy|December 5, 2017
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotypeGeorgia Minakaki, Stefanie Menges, Agnes Kittel, et al.
Neuron|September 4, 2015
Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy PathogenesisYingjun Zhao, I-Chu Tseng, Charles J Heyser, et al.
Frontiers in Neuroscience|August 18, 2025
Correction: Nicotine-mediated effects in neuronal and mouse models of synucleinopathyMohamed Bilal Fares, Omar Alijevic, Stephanie Johne, et al.
Frontiers in Neuroscience|September 18, 2023
Nicotine-mediated effects in neuronal and mouse models of synucleinopathyMohamed Bilal Fares, Omar Alijevic, Stephanie Johne, et al.
Neurobiology of Disease|August 25, 2019
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivoDarren J Schofield, Lorraine Irving, Laura Calo, et al.
Brain : a Journal of Neurology|September 29, 2016
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's diseaseWolfgang Wrasidlo, Igor F Tsigelny, Diana L Price, et al.
Pageof 17